Loading clinical trials...
Loading clinical trials...
LCCC 1027: Expression Of P16INK4a As A Predictor Of Myelosuppression In Patients With Breast Cancer
Conditions
Locations
1
United States
University of North Carolina
Chapel Hill, North Carolina, United States
Start Date
December 1, 2010
Primary Completion Date
April 3, 2014
Completion Date
September 25, 2023
Last Updated
September 19, 2024
NCT04541381
NCT05468034
NCT03137095
NCT07547774
NCT07040891
NCT06393374
Lead Sponsor
UNC Lineberger Comprehensive Cancer Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions